Commit To Purchase Navidea Biopharmaceuticals At $1, Earn 13.3% Annualized Using Options
December 01, 2014 at 11:46 AM EST
Investors considering a purchase of Navidea Biopharmaceuticals, Inc. (NAVB) shares, but cautious about paying the going market price of $1.26/share, might benefit from considering selling puts among the alternative strategies at their disposal..